Navigation Links
Alexander Proudfoot Appoints Executive Vice President for Life Sciences
Date:7/19/2013

Atlanta, Georgia (PRWEB) July 19, 2013

Alexander Proudfoot Company (http://www.alexanderproudfoot.com) announces the appointment of Richard Denness as Executive Vice President for its Life Sciences Practice. Denness, a recognised industry leader further strengthens the firm’s fast-growing practice.

Luiz Carvalho, Chief Executive Officer said “Richard’s wealth of experience and industry knowledge makes him a key addition to the Alexander Proudfoot family, as we look to further develop our offerings to companies across this important sector. Richard is a leading Life Sciences expert with over 24 years of in depth and wide ranging experience. I am confident his appointment will strengthen our ability to deliver significant improvements to companies throughout the sector.”

The Life Sciences sector is an industry in transformation. Following years of growth, companies now face a new era and one distinguished by a changing healthcare landscape, pricing pressures, heightened regulatory scrutiny, increasing alliances and acquisitions as well as expiring patents and increased competition from generics. Companies are under pressure to change—and quickly as they look to meet these challenges head on.

Over the past 67 years, Alexander Proudfoot has been partnering with numerous companies in the sector. However, the current industry challenges will require additional resources. As Executive Vice President for Alexander Proudfoot’s Life Sciences Practice, Denness will lead the firm’s efforts to enhance and expand the services offered to clients across the sector.

A graduate from Missouri State University, he understands the global environment and the challenges facing Life Sciences companies, having worked in Asia-Pacific, Europe, Canada, and the US. He has direct experience of driving revenue, building brands, and greatly improving profitability. He has held various executive leadership roles, including General Manager, Australia and New Zealand with Schering-Plough, President of IVAX Laboratories, Vice President, Managed Care at UCB, Vice President and General Manager of UCB’s Central Nervous System business unit, and CEO of Vycor Medical.

Richard Denness comments “I am excited to start a new challenge within Alexander Proudfoot and look forward to working with the team to further develop Life Sciences. I am fortunate to be joining such a respected company that prides itself on transforming business performance.”

Mr Denness will be based out of Alexander Proudfoot’s Atlanta headquarters.

About Alexander Proudfoot
Alexander Proudfoot is in the business of driving disciplined execution within its client’s organization, enabling it to measure and achieve its growth targets, revenue and profit goals with greater speed, predictability, and control. For over 65 years, Alexander Proudfoot has been the firm of choice for business executives seeking new and innovative ways to rapidly improve operational performance.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10933279.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Alexander Fleming on Searching for Solutions to Metabesity and Healthy Aging
2. KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer
3. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
4. Organovo Appoints Tamar D. Howson to Board of Directors
5. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
6. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
7. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
8. Envera Appoints Michael McErlean Fermentation Manager
9. WMIS Appoints Lisa Baird as Next Executive Director
10. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
11. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can fast-track ... uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect saliva ... , the relationship between insulin and other relevant biomarkers can be extensively studied ...
(Date:2/23/2017)... 2017  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company ... announced that Linda Marbán, Ph.D, president and chief executive officer, ... Cowen and Company 37th Annual Health Care ... Boston, MA 29th Annual ... (12:00 pm ET) Dana Point, CA ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... , Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: ... and commercialization of innovative biopharmaceutical products for companion animals, will ... at 8:30 a.m. ET to discuss financial results from the ... Interested participants and investors may access the ... ...
Breaking Biology Technology:
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... growing genetic information companies, today announced that it will ... and provide 2017 guidance on Monday, February 13, 2017, ... that day at 4:45 p.m. Eastern / 1:45 p.m. ... team will briefly review financial results, guidance, and recent ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements of ... (IAM) lifecycle is comprised of a comprehensive set ... purpose of maintaining digital identities and providing a ... applications. There are significant number of programs opted ... to time by optimizing processes and changing policies. ...
(Date:1/23/2017)... , Jan. 23, 2017  The latest mobile market ... prices have dropped dramatically. The quarterly average price of ... to $276 in Q4 2016.  There are now 120 ... of $116, up from just 28 a year ago ... According to Maxine Most , Acuity Market Intelligence ...
Breaking Biology News(10 mins):